F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 55 filers reported holding F-STAR THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 14.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $56,000 | – | 15,865 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 714,285 | $6,136,000 | 1.28% |
| Boxer Capital, LLC | 1,751,428 | $15,045,000 | 0.53% |
| Atlas Venture Advisors, Inc. | 574,996 | $4,939,000 | 0.51% |
| Monashee Investment Management LLC | 400,000 | $3,436,000 | 0.41% |
| Connolly Sarah T. | 53,001 | $455,000 | 0.37% |
| Rock Springs Capital Management LP | 1,054,232 | $9,056,000 | 0.18% |
| Eversept Partners, LP | 100,000 | $859,000 | 0.06% |
| Maven Securities LTD | 144,932 | $1,257,000 | 0.05% |
| Point72 Asset Management, L.P. | 1,075,000 | $9,234,000 | 0.04% |
| Private Capital Advisors, Inc. | 13,083 | $112,000 | 0.02% |